Tenet Health (THC) fundamentals: P/E, valuation, undervalued?
Tenet Health · Health Care · ref. ETF XLV · price $267.75
In short — Tenet Health trades at 10.6× earnings (P/E), 12.8× forward, with a net margin of 10.3 % and revenue growth of +7 %. Read: Cheap for the growth (P/E 13 for ~213% growth (PEG 0.1)).
Is Tenet Health stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$267.75+45.1% over range
Aug 28, 25low $161.37 · high $280.77Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
92% recommend buying · 12 analysts
Valuation : Cheap for the growth — P/E 13 for ~213% growth (PEG 0.1)
Valuation
10.6
P/E (price/earnings)
12.8
Forward P/E
0.05
PEG
4.6
Price/book (P/B)
$21.6B
Market cap
25.28
EPS
Profitability & growth
10.3 %
Net margin
+7 %
Revenue growth
+213 %
Earnings growth
$13.2B
Total debt
Tenet Health income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $19.2B | $411M | 2.1 % |
| 2023 | $20.5B | $611M | 3.0 % |
| 2024 | $20.7B | $3.2B | 15.5 % |
| 2025 | $21.3B | $1.4B | 6.6 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Tenet Health's P/E and is the stock undervalued? What's a good P/E?
Tenet Health's P/E is 10.6 (forward 12.8). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".
Is Tenet Health profitable?
Tenet Health has a net margin of 10.3 % (EPS 25.28). The company is profitable.
Is THC stock expensive?
Our read: "Cheap for the growth" — P/E 13 for ~213% growth (PEG 0.1). Cross-check with growth and sector.
💬 A question about Tenet Health? The JPI assistant answers using our backtest data.